Francesco Marampon

Pubblicazioni

Titolo Pubblicato in Anno
MiR-200c-3p contrasts PD-L1 induction by combinatorial therapies and slows proliferation of epithelial ovarian cancer through downregulation of β-Catenin and c-Myc CELLS 2021
OTX015 epi‐drug exerts antitumor effects in ovarian cancer cells by blocking GNL3‐mediated radioresistance mechanisms: Cellular, molecular and computational evidence CANCERS 2021
Adjuvant vaginal interventional radiotherapy in early-stage non-endometrioid carcinoma of corpus uteri: a systematic review JOURNAL OF CONTEMPORARY BRACHYTHERAPY 2021
Muscle damage in systemic sclerosis and CXCL10: the potential therapeutic role of PDE5 inhibition INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2021
Dnmt3a and dnmt3b targeting as an effective radiosensitizing strategy in embryonal rhabdomyosarcoma CELLS 2021
Strategies for bone regeneration: from graft to tissue engineering INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2021
Multiple antitumor molecular mechanisms are activated by a fully synthetic and stabilized pharmaceutical product delivering the active compound sulforaphane (SFX-01) in preclinical model of human glioblastoma PHARMACEUTICALS 2021
Deep seated tumour treatments with electrons of high energy delivered at FLASH rates: the example of prostate cancer FRONTIERS IN ONCOLOGY 2021
Treatment in locally advanced rectal cancer: a machine learning bibliometric analysis THERAPEUTIC ADVANCES IN GASTROENTEROLOGY 2021
MS−275 (Entinostat) promotes radio-sensitivity in PAX3-FOXO1 rhabdomyosarcoma cells INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2021
Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtype INTERNATIONAL JOURNAL OF RADIATION BIOLOGY 2021
Locally advanced rectal cancer. Treatment approach in elderly patients CURRENT TREATMENT OPTIONS IN ONCOLOGY 2020
Modulating the dose-rate differently affects the responsiveness of human epithelial prostate- and mesenchymal rhabdomyosarcoma-cancer cell line to radiation INTERNATIONAL JOURNAL OF RADIATION BIOLOGY ONLINE 2020
BET inhibition therapy counteracts cancer cell survival, clonogenic potential and radioresistance mechanisms in rhabdomyosarcoma cells CANCER LETTERS 2020
Bone control of muscle function INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2020
Antitumorigenic effects of inhibiting ephrin receptor kinase signaling by GLPG1790 against colorectal cancer cell lines In vitro and In vivo JOURNAL OF ONCOLOGY 2020
One-week vaginal brachytherapy schedule as exclusive adjuvant post-operative treatment in intermediate- and high-intermediate-risk endometrial cancer patients JOURNAL OF CONTEMPORARY BRACHYTHERAPY 2020
The role of vaginal brachytherapy in stage I endometrial serous cancer. a systematic review JOURNAL OF CONTEMPORARY BRACHYTHERAPY 2020
Clinically relevant radioresistant rhabdomyosarcoma cell lines: functional, molecular and immune-related characterization JOURNAL OF BIOMEDICAL SCIENCE 2020
Toll-iike receptor-3 activation enhances malignant traits in human breast cancer cells through hypoxia-inducible factor-1α ANTICANCER RESEARCH 2020

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma